Abich Financial Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$460K Buy
+10,199
New +$476K 0.16% 38
2024
Q3
$73K Buy
1,411
+1,351
+2,252% +$63.4K 0.16% 68
2024
Q2
$2.49K Sell
60
-2,919
-98% -$131K ﹤0.01% 444
2024
Q1
$162K Buy
2,979
+1,035
+53% +$52.7K 0.12% 42
2023
Q4
$99.7K Buy
+1,944
New +$102K 0.1% 40

Other funds holding BMY

Abich Financial Wealth Management's BMY Position: Q3 2025 in Review

Abich Financial Wealth Management opened a new position in Bristol-Myers Squibb (BMY) in Q3 2025: 10,199 shares worth $460K. The stake represents 0.16% of the portfolio and ranks #38 among its holdings. This is a return to the name: Abich Financial Wealth Management previously reported a position in BMY as recently as Q3 2024.

Abich Financial Wealth Management first reported a position in BMY in Q4 2023 and has held it in 5 quarters since. 2,268 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Abich Financial Wealth Management held 10,199 shares of Bristol-Myers Squibb worth $460K as of Q3 2025.
  • Bristol-Myers Squibb was a new Abich Financial Wealth Management position in Q3 2025.
  • Bristol-Myers Squibb made up 0.16% of Abich Financial Wealth Management's portfolio in Q3 2025, its #38 holding.
  • Abich Financial Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 5 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Abich Financial Wealth Management's 13F filing for Q3 2025, filed 6 Nov 2025.